期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Glyphosate-based herbicide: a risk factor for demyelinating conditions of the peripheral nervous system? 被引量:1
1
作者 Fabian Szepanowski christoph kleinschnitz Mark Stettner 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第12期2079-2080,共2页
Glyphosate is a broad-spectrum herbicide originally introduced to the market in 1974 by the agrochemical company Monsanto. More than 40 years down the line, glyphosate has become one of the most economically meaningfu... Glyphosate is a broad-spectrum herbicide originally introduced to the market in 1974 by the agrochemical company Monsanto. More than 40 years down the line, glyphosate has become one of the most economically meaningful herbicides, with a global use of more than 1.8 million pounds in 2014 (Benbrook, 2016). In non resistant plants, glyphosate is widely believed to exert its herbicidal effect via inhibition of the 5-enolpyruvylshikimate-3-phosphate synthase, an enzyme of the shikimate pathway required for the biosynthesis of aromatic amino acids in plants and most microorganisms such as fungi, bacteria and some protozoans. 展开更多
关键词 Glyphosate-based HERBICIDE BROAD-SPECTRUM HERBICIDE economically meaningful herbicides
下载PDF
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve
2
作者 Fabian Szepanowski Rebecca D.Steubing +4 位作者 Cansu Güngör Jaqueline Zipfel Anne K.Mausberg christoph kleinschnitz Mark Stettner 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第7期1623-1624,共2页
Dear editor,Dysregulated inflammatory responses primarily account for damage to the central nervous system,however,neurodegenerative processes likely contribute to the pathophysiology of progressive forms of multiple ... Dear editor,Dysregulated inflammatory responses primarily account for damage to the central nervous system,however,neurodegenerative processes likely contribute to the pathophysiology of progressive forms of multiple sclerosis(MS).These pathophysiological aspects include axonal energy depletion and impaired remyelination capacity(Levin et al.,2014).The clinical efficacy of most disease-modifying therapies in MS to date has been achieved by targeting functions of the adaptive immune system(Cree et al.,2019;Szepanowski et al.,2021). 展开更多
关键词 system SYNTHESIS NEITHER
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部